← Back to Clinical Trials
Recruiting NCT05286151

NCT05286151 Network Connectivity and Temporal Processing in Adolescents Who Stutter

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05286151
Status Recruiting
Phase
Sponsor University of Michigan
Condition Stuttering, Childhood
Study Type INTERVENTIONAL
Enrollment 500 participants
Start Date 2022-07-23
Primary Completion 2027-01-31

Eligibility & Interventions

Sex All sexes
Min Age 9 Years
Max Age 13 Years
Study Type INTERVENTIONAL
Interventions
Rhythm discrimination

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 500 participants in total. It began in 2022-07-23 with a primary completion date of 2027-01-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The specific purpose of this clinical trial is to compare performance on rhythm perception and production tasks between children who stutter and children who do not stutter. The overall project also aims to investigate how performance on rhythm tasks may be related to brain activity (non-clinical trial).

Eligibility Criteria

Inclusion Criteria Children who stutter: * English as primary language * Current or past stuttering diagnosis Inclusion Criteria Children who do not stutter: * English as primary language Exclusion Criteria Children who stutter: * Diagnosed/under treatment for any neurological or psychiatric conditions * Head trauma with loss of consciousness * Major medical illness * Hearing loss- Language/motor delay (below -2 standard deviations on standardized assessments) * Face, motor, or reflex abnormalities Exclusion Criteria Children who do not stutter: * Personal or family history of stuttering * Diagnosed/under treatment for any neurological or psychiatric conditions * Head trauma with loss of consciousness * Major medical illness * Hearing loss * Language/motor delay (below -2 standard deviations on standardized assessments * Face, motor, or reflex abnormalities

Contact & Investigator

Central Contact

Soo-Eun Chang, PhD

✉ sooeunc@umich.edu

📞 734-232-0300

Principal Investigator

Soo-Eun Chang, PhD

PRINCIPAL INVESTIGATOR

University of Michigan

Frequently Asked Questions

Who can join the NCT05286151 clinical trial?

This trial is open to participants of all sexes, aged 9 Years or older, up to 13 Years, studying Stuttering, Childhood. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05286151 currently recruiting?

Yes, NCT05286151 is actively recruiting participants. Contact the research team at sooeunc@umich.edu for enrollment information.

Where is the NCT05286151 trial being conducted?

This trial is being conducted at Ann Arbor, United States.

Who is sponsoring the NCT05286151 clinical trial?

NCT05286151 is sponsored by University of Michigan. The principal investigator is Soo-Eun Chang, PhD at University of Michigan. The trial plans to enroll 500 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology